Hemofilters for in vivo filtration of blood are disclosed. The hemofilters disclosed herein provide an optimal flow of blood through the filtration channels while maintaining a pressure gradient across the filtration channel walls to enhance filtration and minimize turbulence and stagnation of blood in the hemofilter.

A dialysis machine having a housing and a monitor is disclosed. Situated on a front side of the housing is a front door, on the top side of which a monitor housing is formed and a monitor is fastened. The monitor is situated, at least in portions, above a top side of the housing. A comparatively low, and therefore ergonomic, storage surface may be formed or situated behind the monitor on the top side of the housing.

The present invention relates to the field of medical devices, more particularly the field of devices for extracting circulating molecules from the blood of a mammal, and their therapeutic uses, in particular in treating sepsis, cytokine release syndrome and/or any other form of systemic inflammatory response or cytokine shock, caused by bacterial, parasitic, fungal or viral infections, in particular caused by a viral infection, for example coronaviruses with human respiratory tract tropism.

A renal therapy machine includes a blood filter including a plurality of porous fibers; a blood circuit in communication with the blood filter; and a dialysate circuit in communication with the blood filter and operable with at least one pump, wherein the renal therapy machine is configured to perform a priming sequence in which a physiologically compatible solution, other than dialysate, primes the blood circuit and is flowed within the fibers and through pores in the fibers of the blood filter, and the pump of the dialysate circuit vents air from the blood filter into the dialysate circuit.

Dialysis systems comprising actuators that cooperate to perform dialysis functions and sensors that cooperate to monitor dialysis functions are disclosed. According to one aspect, such a hemodialysis system comprises a user interface model layer, a therapy layer, below the user interface model layer, and a machine layer below the therapy layer. The user interface model layer is configured to manage the state of a graphical user interface and receive inputs from a graphical user interface. The therapy layer is configured to run state machines that generate therapy commands based at least in part on the inputs from the graphical user interface. The machine layer is configured to provide commands for the actuators based on the therapy commands.

This disclosure relates to dialysis systems and methods. In some implementations, a dialysis system includes a dialysis machine with a fluid line and a drain line, a blood line set configured to be connected to the dialysis machine, and a drain apparatus coupled to the dialysis machine. The drain apparatus includes a chamber configured to receive an end of a patient line of the blood line set, an inlet line, an outlet line, and a valve. The inlet line has a first end configured to be coupled to the chamber and a second end configured to be coupled to the fluid line of the dialysis machine. The outlet line has a first end configured to be coupled to the chamber and a second end configured to be coupled to the drain line of the dialysis machine. The valve is configured to control flow of fluid through the outlet line.

The present disclosure relates to bundles of hollow fiber membranes and a process for their production. The bundles are used for the manufacture of filtration and/or diffusion devices, e.g., capillary dialyzers.

In a blood purification device containing a blood purifier, a blood circuit, a blood pump, and a dialysate line having a fresh dialysate supply line and a used dialysate discharge line, a pair of plunger pumps are disposed in the dialysate line. The pair of plunger pumps are synchronized so that delivery of a fresh dialysate from one plunger pump and suction of a used dialysate into the other plunger pump simultaneously occur and the stroke of at least one of the pair of plunger pumps is made variable.

A method of controlling a medical fluid therapy machine display brightness includes: performing a medical fluid therapy using the medical fluid therapy machine, the medical fluid therapy machine including a display; sensing an amount of ambient light impinging the display without receiving light directly from the display; controlling a level of backlight brightness for the display based on the amount of ambient light sensed; and displaying information relating to the medical fluid therapy on the display using the controlled level of backlight brightness.

Some embodiments comprise membranes comprising a first layer comprising a porous graphene-based material; a second layer comprising a porous graphene-based material; a channel positioned between the first layer and the second layer, wherein the channel has a tunable channel diameter; and at least one spacer substance positioned in the channel, wherein the spacer substance is responsive to the environmental stimulus. In some cases, the membranes have more than two layers of porous graphene-based material. Permeability of a membrane can be altered by exposing the membrane to an environmental stimulus. Membranes can be used in methods of water filtration, immune-isolation, timed drug release (e.g., sustained or delayed release), hemodialysis, or hemofiltration.